This post originally appeared on Fast Data Science’s blog on LinkedIn.
Clinical trials, the backbone of medical science advancement, often grapple with high costs, complexity, and lengthy timelines. Fast Data Science presents Fast Clinical AI, a game-changing solution that harnesses the power of Natural Language Processing (NLP) and predictive modelling to tackle these challenges head-on.
Fast Clinical AI automates the extraction of critical information from trial protocols, significantly reducing manual efforts. This tool identifies risk factors and predicts costs and enrolment criteria, ensuring efficient trial planning and execution.
By identifying potential risks early in the trial process, Fast Clinical AI allows researchers to take proactive measures, minimising the chances of trial delays or failures. This proactive approach ensures that trials are faster and more reliable.
Fast Clinical AI helps predict and manage the costs associated with clinical trials, ensuring better resource allocation. Reducing manual efforts and streamlining processes significantly reduces the time required to bring new treatments to market.
Explore how Fast Clinical AI can revolutionise your clinical trials. Visit here for more details. Learn more about clinical trial cost modelling with NLP and AI here. Connect with us today to see how we can support your clinical trial efforts. Let’s innovate together!
#ClinicalTrials #AI #NLP #HealthcareInnovation #FastClinicalAI
Estimating the total cost of a clinical trial before it runs is challenging. Public data on past trial costs can be hard to come by, as many companies guard this information carefully. Trials in high income countries and low and middle income countries have very different costs. Upload your clinical trial protocol and create a cost benchmark with AI Protocol to cost benchmark The Clinical Trial Risk Tool uses AI and Natural Language Processing (NLP) to estimate the cost of a trial using the information contained in the clinical trial protocol.
You can download a white paper about clinical trial cost benchmarking here Estimating the total cost of a clinical trial before it runs is challenging. Public data on past trial costs can be hard to come by, as many companies guard this information carefully. Trials in high income countries and low and middle income countries have very different costs. Clinical trial costs are not normally distributed.[1] I took a dataset of just over 10,000 US-funded trials.
Guest post by Safeer Khan, Lecturer at Department of Pharmaceutical Sciences, Government College University, Lahore, Pakistan Introduction The success of clinical studies relies heavily on proper financial planning and budgeting. These processes directly impact key factors such as project timelines, resource allocation, and compliance with regulatory requirements. The accurate forecasting of costs for clinical trials, however, is a highly complex and resource-intensive process. A study by the Tufts Center for the Study of Drug Development found that the average cost of developing a new drug is approximately $2.
